BLOG
The 5 Qs of Comms: Connecting business goals to effective strategies for life science communications and marketing
The 5-step the framework we use to develop effective life science comms and content strategies, and create content that lands.
You need to “sort your comms out”. But what does that actually mean?
Our trouble-shooting guide for growing biotech companies that know they need to sort their communications and PR out, but aren’t sure where to start.
Creating an eye-catching brand and website for a radiotherapy innovator
We co-developed a new brand, product ecosystem and website for Betaglue to match the potential and calibre of their medtech platform.
How we use AI at First Create The Media
Here’s how we currently use AI-enhanced tools at First Create The Media (and what we don’t use them for), as well as the principles we follow.
Credibility, differentiation, awareness: the three pillars of effective life science comms and marketing
Our Head of Creative Lauren Gray digs into the three pillars that underpin life science comms and marketing: credibility, differentiation and awareness.
When It Comes to Biotech Fundraising, the Data Doesn’t Speak for Itself
Our founder and Chief Creative Officer Kat Arney explores what biotech companies need to be thinking about to secure investment in todays tough climate.
“We call you First Create The Magic!”
How we brought creativity and consistency to nonclinical development consultancy Leads To Development’s marketing communications.
From features to feelings: how to create life science messaging that lands
We show how life science product and service companies can move their messaging from just explaining what they do to articulating why it matters.
Coming out of stealth mode with a splash
How we raised awareness of innovative techbio startup Etcembly at a crucial time in their growth journey.
Comms advice for biotech startups after raising Series A: From startup to scaleup
How biotech companies can build consistent, credible communications as they transition from startup to scaleup following a Series A raise.